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Introduction: The advancement in oesophageal cancer care during the last two decades has resulted in
a decrease in the use of feeding jejunostomy catheter to maintain adequate nutrition. We aim to examine
the validity of feeding jejunostomy catheter in maintaining adequate nutrition for patients with oeso-
phageal cancer.
Patients and Methods: A prospective longitudinal study was conducted on oesophageal cancer patients
presenting to Khartoum Teaching Hospital with complete dysphagia between June 2005 and September
2007. Nutritional assessment was performed pre- and post-insertion of the feeding jejunostomy catheter
and data were tested for any signiﬁcant difference.
Results: Among 99 patients enrolled in the study, 48 had the feeding catheter inserted during oeso-
phagectomy, 41 prior to neoadjuvant therapy and 10 as a palliative measure. Catheter dislodgement
occurred in 3% of patients while blockage occurred in 10% and migration in only 1%. The mean  SD of
patients’ weight pre-insertion was 48.08  10.29, while the mean  SD weight on day 10 post-insertion
was 48.41  10.27 and on day 30 was 48.14  10.29. Patients on jejunostomy catheter feeding were
considered optimised to receive neoadjuvant therapy based on clinical assessment, mobility and sense of
well being. The post-resection mortality rate was 11.5% vs 10% compared to patients on oral feeding.
Conclusion: Jejunostomy feeding catheter provided nutritional access to oesophageal cancer patients
with complete dysphagia using a locally prepared formula. Patients managed to maintain their weight up
to 30 days post-insertion of the feeding catheter. Feeding jejunostomy catheter in combination with
a locally prepared feeding formula provided a reliable nutritional option for oesophageal cancer patients
in developing countries.
 2010 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Malnutrition in hospitalized patients often goes unrecognized.1 It
has a prevalence of 30e40% of hospitalized patients, 40% of them are
malnourished at the time of admission.2 Oesophageal cancer is the
most common GI cancer in The Sudan and patients often have
advanced disease at presentation,3 they are dehydrated and
malnourished making rehydration and feeding an emergency initial
step in the management. The clinical impact of malnutrition on
patientswith oesophageal cancer is signiﬁcant. The nutritional status
of oesophageal cancer patients correlates with surgical resectability,
response to chemotherapy, length of hospital stay and overall
survival.4,5 Signiﬁcant weight loss prior to surgery is also associated
withsubstantiallyhigherpostoperativemorbidityandmortality rates
in patients with oesophageal cancer. Similar observations are made
among patients who underwent surgery for other malignancies.6icine, University of Khartoum,
1 249 249183782663.
ed).
ciates Ltd. Published by Elsevier LtEnteral nutrition is becoming increasingly popular specially
with the improvement of nutritional formula, advancement in
feeding catheters technology, and development of less invasive
techniques (including endoscopic, ﬂuoroscopic and laparoscopic
techniques) for insertion of the feeding catheter.7 Parentral nutri-
tion is not only an expensive route of nutrition but is a second
choice to enteral feeding even in developed countries.
Most often oesophageal cancer patients present with complete
dysphagia secondary to complete occlusion of the lumen by the
tumour making the introduction of a naso-gastric tube impos-
sible. Even those having a naso-gastric feeding tube inserted
experience a range of complications depending on the type of
feeding tube used. Regular size tubes carry the risk of discomfort,
pain, nasal septal irritation with or without necrosis and oeso-
phageal perforation. Fine-bored tubes are associated with recur-
rent blockage, displacement and dislodgement.8,9 The use of
expansile stents remain a more favoured option in these patients
but they still carry a 17% risk of fatal complications and are
generally expensive and unavailable in many developing
countries.10d. All rights reserved.
Table 1
A locally made formula for feeding jejunostomy.
Type Average amount/day The contents Kcal
Water 500 ml/day e e
Soup 500 ml/day Chicken meat, potato,
onion and carrot
288.3
Green vegetables soup 202
Nisha 250 ml/day Milk, egg, wheat and sugar 590.5
Juice 250 ml/day Orange and sugar 160
Yoghourt 500 ml/day Yoghourt 295
Kwash Milk 1500 ml/day Milk, eggs sugar and oil 1500
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access inproviding nutritional support for patientswith oesophageal
carcinomaand toassess theeffectivenessof a locallyprepared feeding
formula in maintaining balanced feed for this cohort of patients.
2. Patients and methods
2.1. Study design
This is a longitudinal study conducted in Khartoum Teaching
Hospital between September 2005 and June 2007. Ninety-nine
patients were found eligible to participate in the study. Ethical
approval for the study was granted and an informed consent was
obtained from all participating patients at the time of enrolment.
Data regarding duration of symptoms, cancer stage, treatment
plan, indication for feeding catheter, associated difﬁculties and
complications were collected using a one-to-one short interview
questionnaire. Pre-insertion patients’ weight was recorded fol-
lowed by weekly weight monitoring to assess progression. Blood
biochemistry was also checked pre-insertion and on day 10 and day
30 post-insertion. These tests included serum levels of total protein,
albumin, total bilirubin, urea nitrogen, and creatinine.
Detailed documentation of post-insertion complications
including infection at the insertion site, intra/retro-peritoneal feed
leakage, nausea, paralytic ileus, feed associated diarrhoea,
abdominal cramps and delayed gastric emptying was performed
regularly. Difﬁculties associated with feeding catheter function and
handling as blockage and dislodgement were recorded. The prog-
ress of all patients, following their discharge from hospital, was
monitored by the lead researcher through regular out patient visits.
2.2. Time of insertion
The jejunostomy feeding catheter was inserted once a treatment
plan has been decided after staging. Patients going directly for
surgical resection had their feeding catheter inserted at the time of
surgery. If surgical resection was delayed for any reason, the cath-
eter was inserted at an earlier date for preoperative nutritional
support after fulﬁlment of inclusion criteria.
2.3. Surgical technique
All jejunostomy catheters were inserted using open technique
under general anaesthesia. Where patient was unﬁt for general
anaesthesia, a combination of local anaesthesia (30 ml of Ligno-
caine 2% diluted 1:2 with Saline 0.9%) and sedation (Pethidine
50 mg or Miazolam 2mg þMetocloperamide 10 mg intravenously)
were used. Combined local anaesthesia and sedation were also
used for some patients with advanced malignancy undergoing
palliative treatment plan.
The abdomen was accessed through an upper midline lapa-
rotomy incision. The abdomen was assessed for tumour mobility,
nodal, hepatic and peritoneal metastasis in order to plan future
treatment. Another 1 cm skin incision was performed on the mid
clavicular line in the left para-umbilical region for insertion of the
feeding catheter through the anterior abdominal wall. A suitable
anti-mesenteric surface of the jejunum approximately 20 cm from
the duodeno-jejunal ﬂexure at the ligament of Treitz was identiﬁed,
a 1 cm jejunostomy was performed and a size 14 Silicon urinary
catheter was used for all patients except patients undergoing neo-
adjuvant therapy or palliative treatment coarse where the size 16
catheter was used. The patient catheter sutured using 3/0 vicryl as
a purse string with submucosal tunnelling of the catheter (Lembert
technique).11 A 10 ml normal saline was injected in the catheter
balloon and a silk stitch was used to ﬁx the catheter to the skin. Thetunnelled jejunal segment with the catheter were secured to the
parietal peritoneum at the site of entrance of the catheter through
the anterior abdominal wall using interrupted 3/0 vicryl stitches.
The patient was kept fasting for 24 h then feeding through the
catheter was started using sterile water at a rate of 10 ml/h for 6-h
followed by locally prepared modiﬁed feed formula at the same
rate. The amount was increased gradually to reach 150 ml/h based
on the patient tolerance to the feed.
2.4. Modiﬁed feed formula
Patients received 3000 ml/day of a locally prepared modiﬁed
feed formula (Table 1). It was made in the hospital from local
ingredients to provide approximately 3000 kcl/day.
2.5. Patient selection
Inclusion criteria
All patients included in this study had the following criteria
fulﬁlled;
- Had a conﬁrmed diagnosis of oesophageal cancer.
- Underwent proper staging and had a treatment plan decided.
- Inability to swallow both ﬂuids and solids or complete
dysphagia (inability to swallow their own saliva).
- Agreed to participate in the study.
Exclusion Criteria;
- Patients with ascites.
- Terminally ill patients.
- Patients with previous gastric, duodenal or small bowel
surgery.
- Patients with small intestinal pathology that could alter the
intestinal response to the feed as Crohn’s Disease, malabsorp-
tion, chronic diarrhoea or intestinal dysmotility.2.6. Data collection and analysis
Data were collected using a computer-generated database
(Microsoft Ofﬁce Access 2003, Microsoft Windows XP Pro-
fessional, Microsoft Corporation, Redmond, WA). Statistical
analysis was performed using SPSS 12.0 software for Windows
(SPSS Inc., Chicago, IL) to calculate the mean, standard deviation
(SD) and the statistical signiﬁcance between the different groups.
The study was designed as a longitudinal study using T-test for
dependent samples to compare between pre- and post intervention
data after a standardized time interval. A P-value of <0.05 and
a power of 0.8 between the two sets of data were used.
3. Results
From a total of 99 patients who underwent insertion of a feeding
jejunostomy catheter, 48 patients had the catheter inserted at the
Fig. 1. Age distribution among patients with feeding jejunostomy.
Table 2
Preoperative and postoperative weight in day 10 and day 30 following Feeding
jejunostomy N ¼ 100 patients.
Mean N Std. Deviation
Preoperative wt 48.08 100 10.2972
Weight in 10th postoperative day 48.41 100 10.2762*
Weight in 30th postoperative day 48.14 52 10.2914*
Correlation is signiﬁcant at the 0.01 level (2-tailed).
* No signiﬁcant change.
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prior to neoadjuvant treatment while 10 had the catheter inserted
as a palliative measure. The mean age SD was 57.4  15.5 (18e93
years) (Fig. 1). The male: female ratio was1: 1.1 (46/54).
Ninety-two patients (92.9%) were illiterate and 85 patients
(85.9%) of low socioeconomic status. All patients (100%) had
dysphagia at the time of presentation of up to 12months maximum
duration, (23.2%) had dysphagia for only 4 months or less (Fig. 2).
Fifty-ﬁve patients (55.5%) had squamous cell carcinoma, 44
patients (44.4%) had adenocarcinoma and one patient (1.1%) had
tracheo-esophageal ﬁstula. No signiﬁcant change in weight was
noted in day 10 and day 30 (Table 2). There was no signiﬁcant
change in the levels of Haemoglobin and serum albumin when
measured pre-insertion and on day 10 and day 30 post-insertion.
When assessing the psychological impact of the feeding cath-
eter on the patients, 86 patients (86.8%) had no difﬁculties related
to the catheter, 50 patients (50.5%) expressed a positive feedback
after resuming feed while 39 patients (39.4%) expressed equivocalFig. 2. Duration of symptoms in patients who underwent feeding jejunostomy.feedback and 10 patients (10.1%) expressed a negative feedback.
Despite the non signiﬁcant improvement in Hb and weight gain,
but the patients general ﬁtness improved and that was reﬂected by
the satisfaction of the treating doctor to offer neoadjuvent therapy
rather than when they arrived earlier more dehydrated and weak.
The overall 30 days mortality on patients with jejunostomy feeding
catherer who had oesophageagl resection was 11.5% compared to
10% among patients on oral feeding who had oesophageal
resection.
Post catheter insertion complications are shown on Table 3. Ten
patients (10.1%) had feeding catheter blockage, three patients
(3.0%) had catheter dislodgement and one patient had catheter
migration.4. Discussion
Oesophageal cancer ranks as the most common gastrointestinal
cancer in The Sudan, the 4th among males and the 5th cancer
among females.12 A striking feature in this study is the increase in
the incidence of adenocarcinoma from 11% during the period
between 1986 and 19913 to 44.5% in this study. This trend is well
documented worldwide with oesophageal adenocarcinoma
increasing by 5e10% annually, recording the highest increasing
incidence among all other types of neoplasms reaching 60e75% in
several western countries,13 while that of squamous cell carcinoma
remained static except of some clusters in the world including
eastern central Africa.14
The decision to use a feeding catheter must address the risks
and beneﬁts involved.15,16 Using an invasive technique for a feeding
catheter in patients with oesophageal cancer is hardly justiﬁed in
many developed countries where alternative feeding accesses such
as endoscopic stenting are easily available. In many developing
countries such as the Sudan, factors as late presentation, complete
dysphagia, both expensive and unavailable stents and feed
formulae make feeding jejunostomy catheter a valid option that
cannot be undermined.
The main presenting symptom was dysphagia over a mean
duration of 5 months in our study, which is consistent with the
median duration of 4e6 months documented inlitreature.17
Patients often presents dehydrated and cachexic to the emer-
gency room were intravenous ﬂuids given and a feeding jejunos-
tomy inserted under general or local anaesthesia. The procedure is
simple and well learned by the residents. There is an added
advantage of intra-operative tumour assessment for feasibility ofTable 3
Gastrointestinal Complications following feeding jejunostomy n ¼ 100.
Complications Frequency Percent (%)
Diarrhea 19 19
Nausea 5 5
Abdominal pain & distension 9 9
Others 0 0
Total 33 33
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peritoneal seedling which both subsidize the cost of further
investigations and dictates early management plan. The local
formula for feeding is simple, of low cost and easily practised at
home (Table 1).
Laparoscopic approach to jejunostomy as ﬁrst described by
O’Regan and Scarrow in 199018 passed through a variety of differing
techniques describing its insertion. These techniques seemed to be
good only in the hands of the people described it as technical
difﬁculties, jejunal suturing difﬁculties and anchoring to anterior
abdominal wall in Stamm fashion. Difﬁculties were all described
not tomention the need for special pre-packaged tubes, T-fasteners
or suturing devices not commonly available.19 In a developing
country, such settings are expensive and require availability in
laparoscopic culture that provides regular training and ﬂuency to
allow practicing such techniques. Moreover, most of these patients
are not suitable for general anaesthesiawhich gives open technique
insertion under local anaesthesia and sedation the advantage on
laparoscopic approach.
The study populationwas able tomaintain a steadyweight post-
insertion of the feeding catheter with no evidence of sever weight
loss as deﬁned by Pennington et al.20 The ability of the palliative
group of patients (10 patients) to maintain a steady weight in spite
of the anticipated malignant cachexia as well as the oesophagec-
tomy group of patients (48 patients) in spite of the catabolic effect
of the operation reﬂects the effectiveness of the jejunostomy
feeding catheter in providing nutritional support for this cohort of
GI malignancy. The patient general improvement is reﬂected by
their satisfaction and sense of well being. Oncologists were more
conﬁdent to provide neoadjuvant therapy. This resulted in a satis-
factory outcome and a 30 days mortality which was comparable to
those taking orally.
The improvement in Hb levels and weight gain, although the
both did not reach a signiﬁcant difference, was reﬂected on the
patients’ general ﬁtness. This improvement encouraged the
medical oncologist to offer neoadjuvant therapy.
Patients who received chemoradiotherapy were able to maintain
their weight during the treatment period, which would have been
nearly impossible to survive it without a nutritional support. The
same group of patients maintained their serum albumin and hae-
moglobin levels for the duration of the treatment in spite of the
knownhaematological changes that accompanychemoradiotherapy.
The feeding catheter was well tolerated by the study population
with 86.8% had no difﬁculties related to the catheter. Catheter
clogging occurred in (10.1%) of the study population, which was
managed using a water ﬂush of the catheter by the patient’s rela-
tives. Patients were advised to sieve the ﬂuid diet through a special
sieve to avoid clogging with larger food particles. Feeding catheter
replacement was required in only two patients after failure of water
ﬂushing. Feeding catheter migration occurred in only one patient,
which was easily retrieved through the skin openening.21 Catheter
dislodgement was the most serious complication that required
exploration for re-insertion in 3.1% of the study population. Similar
ﬁndings were demonstrated by Han-Geurts et al.22,23
The presence of diarrhoea in only 19.2% of the study population
reﬂected an overall good tolerance of the feed by the participants. It
occurred mostly on day 2 post-insertion (52.6%) and was success-
fully treated in most of the cases by decreasing the feed volume for
few days and increasing it again when the diarrhoea settled. Fast
rate feeding is the most reasonable explanation for the diarrhoea as
slowing the down the rate has improved the diarrhoea dramatically
in most cases. In the two cases were diarrhoea did not improve,
feed dilution and increase in the ﬁbre content of the feed has
slightly improved the diarrhoea. These ﬁndings were compatible
with the ﬁndings of Heslin et al21 and the postulation ofhyperosmolality and low ﬁbre content of the feed as possible causes
of diarrhoea.
Deliberate semi-starvation for 24 weeks was studied by Brozek
et al24 among healthy male volunteers. The studied volunteers who
lost up to 25% of their weight became depressed, anxious, irritable,
and apathetic; they also lost muscle strength and physical capacity.
In this study, 50.5% of the patients improved psychologically, 39.4%
with no change and only 10.1% were depressed.
While this study showed that enteral feeding via jejunostomy
feeding catheter using a locally prepared formula maintained
reasonable body weight and nutritional status in a group of oeso-
phageal cancer patients, it required great deal of effort and
commitment by the patient and family. They both had to undertake
certain restrictions in their daily activities and lifestyle.
5. Conclusion
Feeding jejunostomy catheter represents a suitable nutritional
access for oesophageal cancer patients with complete dysphagia
especially in developing countries where alternative methods of
improving enteral feeding as expansile stents are unaffordable and
not easily feasible. It also gives a chance to assess tumour resect-
ability and hence plan future management. It is a good temporary
measure until the patient can resume feeding after surgery or
chemoradiotherapy. However, in a few patients with advanced
disease it is the only available cheapmodality possibly to be offered.
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